Site Search

... Relations Director Michael Davoli: “In 2023, New York State delivered for its residents, prioritizing access to care with the passage of the biomarker testing bill. This legislation will equip countless New Yorkers who have received a cancer diagnosis with critical information about their disease ... their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it.  0 Four weeks after historic biomarker testing bill was signed into law, ACS CAN reacts to Governor’s budget and unveils its legislative vision for 2024 Advocates Set Sights ...